Interferon alpha for alveolar soft part sarcoma [2]

Pediatric Blood and Cancer

Volumn 44, Issue 7, 2005, Pages 687-688

  Bisogno, Gianni ^a   Rosolen, Angelo ^a   Carli, Modesto ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA2B INTERFERON; CYCLOPHOSPHAMIDE; PREDNISONE; TOPOTECAN;

ALVEOLAR SOFT PART SARCOMA; BIOPSY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; GOOD GENERAL CONDITION; HUMAN; LETTER; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; CHILD; FEMALE; HUMANS; INTERFERON ALFA-2B; SARCOMA, ALVEOLAR SOFT PART; TREATMENT OUTCOME;

EID: 18244373420     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20303     Document Type: Letter

References (4)

1. Casanova M, Ferrari A, Bisogno G, et al. Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol 2000;11:1445-1449.
2. Kuriyama K, Todo S, Hibi S, et al. Alveolar soft part sarcoma with lung metastases. Response to Interferon alpha-2a. Med Pediatr Oncol 2001;37:482-483.
3. Roozendal KJ, deValk B, ten Velden JJA, et al. Alveolar soft-part sarcoma responding to interteron alpha-2b. Brit J Cancer 2003; 89:243-245.
4. Rosolen A, Todesco A, Colamonici OR, et al. Expression of type 1 interferon receptor in solid tumors in childhood. Mod Pathol 1997; 10:55-61.